EOLS Evolus, Inc.
$7.00
Evolus, Inc. (EOLS) Earnings News
Earnings press releases, previews and reviews for Evolus, Inc. (EOLS), newest first. Our most recent is review: Evolus Misses on EPS as Growth Cools From Q2, Leaving the Reaffirmed Outlook Dependent on a Steep Fourth-Quarter Ramp.
Wednesday
November 4, 2026
7:04 PM ET
Evolus Misses on EPS as Growth Cools From Q2, Leaving the Reaffirmed Outlook Dependent on a Steep Fourth-Quarter Ramp
Earnings Whispers · Review
Wednesday
November 4, 2026
4:05 PM ET
Evolus Reports Third Quarter 2026 Financial Results with 13% Year-Over-Year Revenue Growth; Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year 2026 Financial Outlook
Tuesday
October 27, 2026
5:26 PM ET
Evolus Must Prove Its Second-Quarter Inflection Can Survive a Seasonal Slowdown
Earnings Whispers · Preview
Wednesday
October 21, 2026
8:30 AM ET
Evolus to Report Third Quarter Financial Results on November 4, 2026
Wednesday
October 14, 2026
8:30 AM ET
Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration Program
Wednesday
August 5, 2026
4:05 PM ET
Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook
Tuesday
August 4, 2026
8:30 AM ET
Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand
Wednesday
July 22, 2026
8:30 AM ET
Evolus to Report Second Quarter Financial Results on August 5, 2026
Wednesday
July 8, 2026
9:00 AM ET
Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality